# Unither Pharmaceuticals

> Unither Pharmaceuticals is a VC fund in Paris backing Health Care and B2B. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 3
- Last investment: Jun 2024
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/unither-pharmaceuticals 
- Website: http://www.unither-pharma.com

Unither Pharmaceuticals is a French manufacturer of dosage forms for pharmaceutical laboratories, and generic products. The world leader in the contract manufacturing of pharmaceutical products.

## Contacts

5 contacts available for Unither Pharmaceuticals. Shizune tracks 2 team members at Unither Pharmaceuticals. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/unither-pharmaceuticals?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Corporate Round | $453k–$963k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| B2B | 1 | 33% |
| SMS | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Corporate Round | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexandre Rochereau | Chief Information Officer | 0 | https://shizune.co/investors/profile/alexandre-rochereau-3e59 |
| Eric Goupil | CEO | 1 | https://shizune.co/investors/profile/eric-goupil-93d7 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BIOPHTA | BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management. | $7.1M | Seed | Jun 03, 2024 |  |
| Curecall | Curecall is a telecare solution that allows healthcare professionals to follow their patients by SMS in a personalized and automated way. | $963.4K | Corporate Round | Apr 19, 2021 |  |
| Curecall | Curecall is a telecare solution that allows healthcare professionals to follow their patients by SMS in a personalized and automated way. | $452.5K | Corporate Round | Jun 23, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [Elaia](https://shizune.co/investors/profile/elaia-partners) — VC Fund, 1 deal together
- [HTL Biotechnology](https://shizune.co/investors/profile/htl) — VC Fund, 1 deal together
- [GO CAPITAL](https://shizune.co/investors/profile/ouest-ventures) — VC Fund, 1 deal together
- [UI Investissement](https://shizune.co/investors/profile/ui-gestion) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Unither Pharmaceuticals invest in?

Unither Pharmaceuticals invests primarily in Health Care, B2B and SMS startups, most often at Seed and Corporate Round stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Unither Pharmaceuticals's check size?

Unither Pharmaceuticals typically joins rounds of $453k–$963k at Corporate Round. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Unither Pharmaceuticals participates in.

### How do I contact Unither Pharmaceuticals?

Public channels for Unither Pharmaceuticals include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Unither Pharmaceuticals?

The team at Unither Pharmaceuticals includes Alexandre Rochereau (Chief Information Officer) and Eric Goupil (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co